Agents and Actions

, Volume 4, Issue 4, pp 227–229 | Cite as

Standardisation of arthritogenic adjuvants for evaluating anti-inflammatory and immunosuppressant drugs

  • Michael W. Whitehouse
  • Frances W. J. Beck
Immunosuppression and Inflammation Editorials
Received:

Abstract

The assistance of interested readers is sought to eliminate one variable factor in drug evaluation using adjuvant disease in rats.

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    K.F. Swingle,Evaluation for Anti-Inflammatory Activity — Adjuvant Induced Arthritis of the Rat, in:Anti-Inflammatory Agents, vol. II (EdsR.A. Scherrer andM.W. Whitehouse; Academic Press, N.Y. 1974), p. 92–105.Google Scholar
  2. [2]
    M.E. Rosenthale,Evaluation for Immunosuppressive and Anti-allergic Activity — Adjuvant Induced Polyarthritis in the Rat, in:Anti-Inflammatory Agents, vol. II (Eds R.A. Scherrer and M.W. Whitehouse; Academic Press, N.Y. 1974), p. 173–178.Google Scholar
  3. [3]
    B.B. Newbould,Chemotherapy of Arthritis Induced in Rats by Mycobacterial Adjuvant, Br. J. Pharmac. Chemother.21, 127–136 (1963).Google Scholar
  4. [4]
    M.W. Witehouse, K.J. Orr, F.W.J. Beck andC.M. Pearson,Freund's Adjuvants: Relationship of Arthritogenicity and Adjuvanticity in Rats to Vehicle Composition, Immunol.27, 311–330 (1974).Google Scholar
  5. [5]
    F.W.J. Beck andM.W. Whitehouse,Drug Sensitivity of Rat Adjuvant Arthritis, Induced with ‘adjuvants’ Containing no Mineral Oil Components, Proc. Soc. exp. Biol. Med.146, 665–669 (1974).PubMedGoogle Scholar
  6. [6]
    M.W. Whitehouse,A Problem of Nomenclature (II): Freund's Adjuvants, Agents and Actions3, 221–222 (1973).CrossRefPubMedGoogle Scholar
  7. [7]
    R.A. Scherrer,Introduction to the Chemistry of Anti-Inflammatory Agents, in:Anti-Inflammatory Agents, vol. I (Eds R.A. Scherrer and M.W. Whitehouse; Academic Press, N.Y. 1974), p. 28–44.Google Scholar
  8. [8]
    D.M. Morton andD.H. Chatfield,The Effects of Adjuvant-Induced Arthritis on the Liver Metabolism of Drugs in Rats, Biochem. Pharmac.19, 473–481 (1970).CrossRefGoogle Scholar
  9. [9]
    F.J. Beck andM.W. Whitehouse,Effect of Adjuvant Disease in Rats on Cyclophosphamide and Isophosphamide Metabolism, Biochem. Pharmac.22, 2453–2468 (1973).CrossRefGoogle Scholar
  10. [10]
    G. di Pasquale, P. Welaj andC.L. Rassaert,Prolonged Pentobarbital Sleeping Time in Adjuvant-Induced Polyarthritic Rats (In preparation).Google Scholar
  11. [11]
    A. Quevauviller, H. Broulhet andM.A.G. Castaneda-Chalchat,Catalepsie par chlorpromazine chez le rat normal ou chez le rat rendu arthritique par adjuvant de Freund, Bull. Acad. Vet.46, 157–160 (1973).Google Scholar
  12. [12]
    A. Quevauviller andM.A.G. Castaneda-Chalchat,Activité de l'ouabaine chez le rat normal ou chezle rat rendu arthritique par adjuvant de Freund, Compt. rend. Soc. Biol.167, 30–33 (1973).Google Scholar
  13. [13]
    G. di Pasquale andP. Welaj,Ulcerogenic Potential of Indomethacin in Arthritic and Non-Arthritic Rats, J. Pharm. Pharmac.25, 831–832 (1973).Google Scholar
  14. [14]
    J.L. Gingold andG. Di Pasquale,Increased Resistance to Lysis of Red Blood Cells from Rats with Adjuvant Arthritis, Life Sci.15, in press (1974).Google Scholar
  15. [15]
    V.N. Lukens, G.E. Cartwright andM.W. Wintrobe,Anemia of Adjuvant-Induced Inflammation in Rats. Proc. Soc. exp. Biol. Med.126, 346–349 (1967).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1974

Authors and Affiliations

  • Michael W. Whitehouse
    • 1
    • 2
  • Frances W. J. Beck
    • 1
    • 2
  1. 1.Department of Experimental Pathology, John Curtin School of Medical ResearchThe Australian National UniversityCanberraAustralia
  2. 2.Department of Medicine/RheumatologyUniversity of California School of MedicineLos AngelesUSA

Personalised recommendations